date/time interval
- September 1, 2022 - August 31, 2025
A hPSC-based multiplex platform to interrogate diabetogenic interactions of T2D-associated genes in human pancreatic beta-cells.
Grant
Overview
awarded by
administered by
sponsor award ID
- 9-22-PDFPM-06
Affiliation
contributor
- Chen, Shuibing Key Personnel 2022 - 2023
- Xue, Dongxiang Principal Investigator 2022 - 2023